Chad Cowan Century Therapeutics, Inc. (IPSC) insider trading activity
Chad Cowan is Chief Scientific Officer of Century Therapeutics, Inc.. Currently has a direct ownership of 210,806 shares of IPSC, which is worth approximately $231,886. The most recent transaction as insider was on Oct 01, 2024, when has been sold 74,376 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
211K
n/a
3M change
n/a
12M change
Total Value Held
$231,886
CC
Chad Cowan
Chief Scientific Officer
Philadelphia, PA